EF
Emily Field Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
0.69%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
50%
Neutral
37.5%
Negative
12.5%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underweight
Initiated
| $25 |
6%
downside
| 1 | +0.93% |
0
%
| 20 Feb ‘26 13 days ago |
|
|
|
Overweight
Initiated
| $140 |
21%
upside
| 1 | -4.8% |
0
%
| 20 Feb ‘26 13 days ago |
|
|
|
Equal-Weight
Initiated
| $155 |
7%
upside
| 1 | – |
–
| 20 Feb ‘26 13 days ago |
|
|
|
Overweight
Initiated
| $1,350 |
37%
upside
| 1 | -3.9% |
0
%
| 20 Feb ‘26 13 days ago |
|
|
|
Overweight
Initiated
| $75 |
23%
upside
| 1 | +0.73% |
0
%
| 20 Feb ‘26 13 days ago |
|
|
|
Equal-Weight
Initiated
| $185 |
2%
downside
| 1 | – |
–
| 20 Feb ‘26 13 days ago |
|
|
|
Equal-Weight
Initiated
| $350 |
5%
downside
| 1 | – |
–
| 20 Feb ‘26 13 days ago |
|
|
|
Overweight
Initiated
| $275 |
18%
upside
| 1 | +3.6% |
0
%
| 20 Feb ‘26 13 days ago |
|